Legislation Includes Measures to Increase Patient and Expert Participation in FDA Review of Rare Disease Drugs
The U.S. House of Representatives and the Senate have both incorporated the Expanding and Promoting Expertise in Review of Rare Treatments Act (EXPERRT Act), championed by the CF Foundation, as part of a legislative package to reauthorize the U.S. Food and Drug Administration's (FDA) system for evaluating new prescription drugs and devices.
|
1 min read
Legislation Would Increase Patient and Expert Participation in FDA Review of Rare Disease Treatments
|
5 min read
Legislation Would Increase Patient and Expert Participation in FDA Review of Rare Disease Treatments
|
3 min read
On March 8, more than 40 Cystic Fibrosis Foundation volunteers from across the nation came together on Capitol Hill to speak out on behalf of their friends and family members with cystic fibrosis.
|
2 min read